Preventing allograft rejection with CTLA4IG: Effect of donor-specific transfusion route or timing

Journal of Heart and Lung Transplantation

Volumn 15, Issue 9, 1996, Pages 928-935

  Bolling, S F ^a   Lin, H ^a   Wei, R Q ^a   Turka, L A ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; THYMUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; DRUG ADMINISTRATION ROUTES; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; MALE; RATS; RATS, INBRED STRAINS; RECEPTORS, ANTIGEN; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029760962     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)